Fascia iliaca compartment block reduces emergence agitation by providing effective analgesic properties in children

Hee-Soo Kim1, Chong Sung Kim, Seong Deok Kim

  • 1Department of Anesthesiology and Pain Medicine, Seoul National University College of Medicine, Seoul 110-744, Korea.

Insights

Fascia iliaca compartment block (FICB) significantly reduced emergence agitation and postoperative pain in pediatric patients undergoing thigh surgery. This effective pain management strategy improved patient outcomes in the PACU.

Area of Science:

  • Anesthesiology
  • Pediatric Surgery
  • Pain Management

Background:

  • Emergence agitation and postoperative pain are common complications in pediatric patients after surgery.
  • Effective pain management strategies are crucial for improving patient recovery and reducing distress.

Purpose of the Study:

  • To evaluate the efficacy of fascia iliaca compartment block (FICB) in reducing emergence agitation in pediatric patients.
  • To compare the effectiveness of FICB with intravenous patient/parent-controlled analgesia (PCA) for postoperative pain management.

Main Methods:

  • A prospective, randomized, blinded clinical trial was conducted involving 64 pediatric patients aged 3-7 years undergoing orthopedic thigh surgery.
  • Patients received either FICB or IV PCA with fentanyl postoperatively.
  • Agitation and pain were assessed using the Pediatric Agitation and Emergence Delirium (PAED) scale and the Children's Hospital of Eastern Ontario Pain Scale (CHEOPS).

Main Results:

  • Patients receiving FICB demonstrated significantly lower PAED scores on PACU arrival compared to the control group (7.3 ± 2.9 vs 10.4 ± 3.2, P < 0.001).
  • FICB group also showed significantly lower CHEOPS pain scores at PACU arrival and 10 minutes post-arrival (P < 0.001 and P = 0.009, respectively).

Conclusions:

  • FICB is an effective method for reducing emergence agitation in pediatric patients undergoing thigh surgery.
  • FICB provides superior postoperative pain relief compared to IV PCA with fentanyl during the immediate postoperative period.
Abstract

Related Concept Videos

Local Anesthetics: Clinical Application as Spinal Anesthesia01:11

Local Anesthetics: Clinical Application as Spinal Anesthesia

Spinal anesthetics are given during lower abdomen and limb surgeries to block sensory and motor neurons. They are administered in the mid to low lumbar regions, primarily acting on the cauda equina's nerve roots. The blockade level depends on the local anesthetic (LA) concentration. Usually, low LA concentrations are sufficient to block sensory fibers, while only high LA concentrations block motor fibers. Other factors like injection volume and speed, the patient's posture, and the drug...
Local Anesthetics: Clinical Application as Epidural Anesthesia01:29

Local Anesthetics: Clinical Application as Epidural Anesthesia

Epidural anesthetics are administered in the fat-filled epidural space, the outermost part of the spinal canal. This technique is commonly employed for pain management and anesthesia during lower abdomen and pelvis surgeries or labor and delivery.
Since epidural anesthetics can be infused through an epidural catheter, all types of drugs, including short-acting ones, can be administered. Chloroprocaine and lidocaine are examples of short and long-duration anesthetics, respectively. Bupivacaine...
Local Anesthetics: Differential Sensitivity of Nerve Fibers01:24

Local Anesthetics: Differential Sensitivity of Nerve Fibers

Local anesthetics (LAs) block the sodium channels of nerve trunks, sensory nerve endings, and neuromuscular junctions. Although LAs can block all kinds of nerves, the sensitivity of nerve fibers differs according to nerve types and structures. LAs are known to block myelinated fibers faster than unmyelinated ones. Also, they block pain or sensory neurons at low concentrations without affecting the motor neurons involved in muscle contractions. This helps relieve labor pain without affecting the...
Drugs for Treatment of Constipation-Predominant IBS01:21

Drugs for Treatment of Constipation-Predominant IBS

Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
Drugs Affecting GI Tract Motility: Opioids as Antidiarrheal Agents01:17

Drugs Affecting GI Tract Motility: Opioids as Antidiarrheal Agents

Diarrhea, a condition marked by frequent loose or watery bowel movements, can be triggered by multiple factors such as viral or bacterial infections, food intolerances, anxiety, medications, and digestive disorders. Symptoms may include abdominal pain, bloating, nausea, and cramping. Severe or prolonged diarrhea can lead to complications like electrolyte imbalances, malnutrition, and dehydration if left untreated.
Opioids, widely used antidiarrheal agents, mitigate diarrhea by slowing down...
Drugs for Treatment of Diarrhea-Predominant IBS01:17

Drugs for Treatment of Diarrhea-Predominant IBS

Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...